Immutep Ltd (NASDAQ:IMMP)

1.82
Delayed Data
As of 12:31pm ET
 -0.0168 / -0.91%
Today’s Change
1.25
Today|||52-Week Range
2.85
+16.13%
Year-to-Date
No recent news for Immutep Ltd.

Today’s Trading

Previous close1.84
Today’s open1.83
Day’s range1.81 - 1.86
Volume4,453
Average volume (3 months)42,990
Market cap$43.9M
Data as of 12:31pm ET, 04/24/2018

Growth & Valuation

Earnings growth (last year)+83.16%
Earnings growth (this year)-15.50%
Earnings growth (next 5 years)+0.00%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book1.87

Competitors

 Today’s
change
Today’s
% change
AEZSAEterna Zentaris Inc-0.02-1.24%
PRTOProteon Therapeutics...-0.05-2.17%
HTGMHTG Molecular Diagno...+0.05+1.47%
FSIFlexible Solutions I...+0.03+1.99%
Data as of 12:56pm ET, 04/24/2018

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$7.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, CFO &
Executive Director
Marc Voigt
COO, Secretary &
General Counsel
Deanne Miller
Corporate headquarters
Sydney, New South Wales (nsw)

Forecasts